Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

 

Gainers

  • Second Sight Medical (NASDAQ:EYES) stock increased by 7.8% to $1.51 during Tuesday's pre-market session. The market value of their outstanding shares is at $59.5 million.
  • Enveric Biosciences (NASDAQ:ENVB) shares increased by 7.4% to $0.67. The company's market cap stands at $21.9 million.
  • Alterity Therapeutics (NASDAQ:ATHE) stock rose 7.11% to $1.05. The company's market cap stands at $42.1 million.
  • Also check out this: Executives Buy Over $6M Of 5 Penny Stocks
  • 180 Life Sciences (NASDAQ:ATNF) shares moved upwards by 6.98% to $3.37. The company's market cap stands at $114.6 million.
  • Sonnet BioTherapeutics (NASDAQ:SONN) shares increased by 6.87% to $0.34. The company's market cap stands at $20.4 million.
  • Achieve Life Sciences (NASDAQ:ACHV) shares moved upwards by 6.39% to $8.15. The market value of their outstanding shares is at $77.0 million.

Losers

  • Nuvectis Pharma (NASDAQ:NVCT) shares fell 13.2% to $6.9 during Tuesday's pre-market session. The company's market cap stands at $81.5 million.
  • Editas Medicine (NASDAQ:EDIT) stock fell 12.01% to $17.0. The company's market cap stands at $1.1 billion.
  • Reviva Pharmaceuticals (NASDAQ:RVPH) stock decreased by 10.92% to $1.55. The market value of their outstanding shares is at $23.4 million.
  • Karyopharm Therapeutics (NASDAQ:KPTI) stock fell 9.77% to $9.24. The company's market cap stands at $698.0 million. As per the press release, Q4 earnings came out today.
  • Novavax (NASDAQ:NVAX) shares fell 9.29% to $86.0. The company's market cap stands at $6.5 billion.
  • Forte Biosciences (NASDAQ:FBRX) shares decreased by 8.98% to $1.42. The market value of their outstanding shares is at $20.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.